Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/12/2014WO2014088432A1 Conjugate compounds
06/12/2014WO2014088386A1 Metformin-orlistat compositions
06/12/2014WO2014088385A1 Stable pharmaceutical composition for treating osteoporosis
06/12/2014WO2014088326A1 Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells
06/12/2014WO2014088315A1 Crystalline doripenem monohydrate, and method for preparing same
06/12/2014WO2014088301A1 Composition for preventing or treating inflammatory diseases or immunological rejection comprising coenzyme q10 as active ingredient
06/12/2014WO2014088292A1 Pharmaceutical composition comprising inhibitor of expression or activation of carbonyl reductase 1 protein for preventing or treating colorectal cancer or inhibiting metastasis of same
06/12/2014WO2014088281A1 Novel method for preparing cabazitaxel from 10-deacetylbaccatin iii in high yield, and novel intermediate therefor
06/12/2014WO2014088129A1 Novel heterocyclic compound
06/12/2014WO2014088123A1 Candesartan cilexetil-containing preparation
06/12/2014WO2014088113A1 Prophylactic or therapeutic method for sjogren's syndrome using specific ccr9 receptor inhibitors/antagonists
06/12/2014WO2014088087A1 Double-stranded ribonucleic acid for adjuvants
06/12/2014WO2014088085A1 Pyridone compound
06/12/2014WO2014087904A1 Agent for preventing or treating osteoclast-induced disease
06/12/2014WO2014087818A1 Orally administered liquid formulation
06/12/2014WO2014087778A1 Tumor cell selective anticancer agent including hydroxyalkylated cyclodextrin
06/12/2014WO2014087626A1 Sema5b peptides and vaccines containing the same
06/12/2014WO2014087429A1 Histidinylated cationic amphiphiles, process for preparation thereof and their liposomal formulation
06/12/2014WO2014087420A1 Oral gel for relief of tooth pain
06/12/2014WO2014087419A1 Oral gel for sensitivity and tooth pain
06/12/2014WO2014087413A1 Nanoparticles comprising sorafenib
06/12/2014WO2014087367A2 Compositions and methods for the treatment of neurological diseases and its associated complications
06/12/2014WO2014087347A1 Fixed dose pharmaceutical composition comprising mometasone and azelastine
06/12/2014WO2014087323A2 Compositions and methods for the treatment of autoimmune and chronic metabolic diseases
06/12/2014WO2014087317A1 Pharmaceutical compositions for treating obesity
06/12/2014WO2014087307A2 Compositions and methods for the treatment of metabolic syndrome and diabetes
06/12/2014WO2014087298A1 Novel selective androgen receptor modulators
06/12/2014WO2014087230A1 Use of eribulin in the treatment of breast cancer
06/12/2014WO2014087226A1 Buprenorphine analogs as opiod receptor modulators
06/12/2014WO2014087165A1 Tankyrase inhibitors
06/12/2014WO2014087110A1 Method for synthesising an addition salt with a pharmaceutically acceptable acid of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, and the associated crystalline forms
06/12/2014WO2014087106A1 Solid dispersion of a selective modulator of the progesterone receptor
06/12/2014WO2014086994A1 Hsp for use in treatment for imiquimod related side effects
06/12/2014WO2014086964A1 New derivatives of indole for the treatment of cancer, viral infections and lung diseases
06/12/2014WO2014086960A1 Triazine formulations with a second active ingredient and surfactant(s)
06/12/2014WO2014086959A1 Treatment of coccidiosis with intramuscular triazine compositions
06/12/2014WO2014086958A1 New treatments with triazines
06/12/2014WO2014086927A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
06/12/2014WO2014086894A1 Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
06/12/2014WO2014086865A1 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors
06/12/2014WO2014086857A1 Oral pharmaceutical composition comprising dabigatran etexilate
06/12/2014WO2014086855A1 Phenylethylpyridine derivatives as pde4-inhibitors
06/12/2014WO2014086852A1 Phenylethylpyridine derivatives as pde4-inhibitors
06/12/2014WO2014086849A1 Phenylethylpyridine derivatives as pde4-inhibitors
06/12/2014WO2014086819A1 Methods and pharmaceutical composition for the treatment and prevention of cardiac arrhythmias
06/12/2014WO2014086807A1 Novel pyrazine derivatives as cb2 receptor agonists
06/12/2014WO2014086805A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086790A1 Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
06/12/2014WO2014086739A1 Novel benzimidazole derivatives as ep4 antagonists
06/12/2014WO2014086712A1 New indanyloxydihydrobenzofuranylacetic acids
06/12/2014WO2014086705A1 Novel pyridine derivatives
06/12/2014WO2014086704A1 Substituted isoxazole amide compounds as inhibitors of stearoyl-coa desaturase 1 (scd1)
06/12/2014WO2014086701A1 Substituted thiazole compounds
06/12/2014WO2014086697A1 Substituted thiazole compounds
06/12/2014WO2014086687A1 A cftr corrector for the teatment of genetic disorders affecting striated muscle
06/12/2014WO2014086679A1 Biodegradable combination for treating diseases in which the intraocular pressure is elevated
06/12/2014WO2014086667A1 Substituted isoxazole amine compounds as inhibitors of scd1
06/12/2014WO2014086664A1 Substituted triazole boronic acid compounds
06/12/2014WO2014086663A1 Substituted triazole and imidazole compounds
06/12/2014WO2014086632A1 An edible composition comprising resveratrol and flavonoid monoglucoside
06/12/2014WO2014086499A1 Neurotensin receptor ligands
06/12/2014WO2014086480A1 Lignan compositions
06/12/2014WO2014086478A1 Inhibitors of malt1 protease
06/12/2014WO2014086379A1 Lignan compositions
06/12/2014WO2014086373A1 Crystallisation of human milk oligosaccharides (hmo)
06/12/2014WO2014086316A1 Substituted pyridopyrazines as syk inhibitors
06/12/2014WO2014086291A1 Method for preparing ticagrelor and intermediates thereof
06/12/2014WO2014086285A1 Antifungal compound and uses thereof
06/12/2014WO2014086284A1 Deuterated 3-cyano quinoline compound, pharmaceutical composition, preparation method and use thereof
06/12/2014WO2014086243A1 Mirna molecule for negatively regulating type i interferon pathway and use thereof
06/12/2014WO2014086127A1 Doxorubicin conjugate medicine and preparation method thereof
06/12/2014WO2014086104A1 Ampk activator and application thereof in preparing drugs for treating diabetes and/or diabetes complications
06/12/2014WO2014086102A1 Indole full ketone derivative used as tyrosine-kinase inhibitor
06/12/2014WO2014086099A1 Glucopyranosyl derivative, preparation method and medical use thereof
06/12/2014WO2014086098A1 Cyclohexane amine compound and application thereof for anti-schizophrenia drugs
06/12/2014WO2014086032A1 Substituted pyridopyrazines as syk inhibitors
06/12/2014WO2014085989A1 Small molecule substance for improving sensitivity of bacteria to antibiotics
06/12/2014WO2014085958A1 Erythromycin derivatives and preparation and use thereof
06/12/2014WO2014085950A1 Medicine for treating blood-heat and damp-heat brew toxicity syndromes of chronic kidney disease
06/12/2014WO2014085920A1 Methods for preventing and treating inflammatory skin conditions
06/12/2014WO2014085914A1 Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
06/12/2014WO2014085909A1 Methods and kits for monitoring response to radiation therapies in cancer
06/12/2014WO2014085884A1 Pharmaceutical composition comprising desloratadine and prednisolone and use thereof
06/12/2014WO2014085866A1 USE OF miRNA ANTAGONISTS FOR IMMUNE SYSTEM MODULATION, TREATMENT OF BACTERIAL INFECTIONS AND TREATMENT OF AIRWAYS DISEASES
06/12/2014WO2014062733A3 Substituted benzene compounds
06/12/2014WO2014057415A3 Inhibitors of dna gyrase for the treatment of bacterial infections
06/12/2014WO2014054975A3 Pharmaceutical composition having a metabolic, anti-cataract, retina-protecting effect (variants)
06/12/2014WO2014047662A3 Indazole derivatives and uses thereof
06/12/2014WO2014044869A3 Medical preparation comprising a carrier and polyhexanide or octenidine
06/12/2014WO2014017915A3 Urea and guanidinium derivatives of iminosugars
06/12/2014WO2013192274A9 Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
06/12/2014WO2013151596A3 System and method of losing weight
06/12/2014WO2013097074A8 Method and improved pharmaceutical composition for enhancing transdermal delivery of pde-5 inhibitor
06/12/2014WO2013064714A8 Drugs for inhibiting p38 and uses thereof
06/12/2014WO2013020097A9 Double-stranded oligonucleotide compounds for treating hearing and balance disorders
06/12/2014US20140165223 Tnf superfamily trimerization inhibitors
06/12/2014US20140163452 Pharmacokinetics of iontophoretic sumatriptan administration
06/12/2014US20140163451 Methods and Compositions for Treating Conditions of the Eye
06/12/2014US20140163371 Tumor tissue reductive procedure under ultrasound observation
06/12/2014US20140163238 Synthesis of tetracyclines and analogues thereof
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 7860